Relay Therapeutics RLAY
NASDAQ RLAY
$18.86 +0.41 (+2.22%)
As of: Oct 21, 2026 · 10:19 AM EDT

Relay Therapeutics (RLAY) Preferred Shares (2019)

Updated

Relay Therapeutics' Preferred Shares was $537.78 million in Q4 2019.

Analysis

Relay Therapeutics (RLAY) Preferred Shares (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,132.91 Bn 1,101.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.07 Bn 533.59 Bn 17.26 Bn -
3 AbbVie 505.92 Bn 479.03 Bn 12.70 Bn -
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn -
5 Novartis Ag 298.25 Bn 262.24 Bn 11.24 Bn -
6 Astrazeneca 261.76 Bn 235.45 Bn 12.86 Bn -
7 Amgen 236.19 Bn 191.59 Bn 7.24 Bn -
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn -
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn -
10 Relay Therapeutics 3.81 Bn 3.31 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 537.78 Mn
API Access

Relay Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=RLAY&period=max&api_key=YOUR_API_KEY